Potential impact of the bivalent rLP2086 vaccine on Neisseria meningitidis carriage and invasive serogroup B disease

類似資料

• Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy Adolescents
  著者:: Vesikari, Timo, 等
  出版事項: (2016)
• Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic Vaccine
  著者:: McNeil, Lisa K., 等
  出版事項: (2018)
• Preclinical evidence for the potential of a bivalent fHBP vaccine to prevent Neisseria meningitidis serogroup C disease
  著者:: Harris, Shannon L, 等
  出版事項: (2011)
• Structure of the uncomplexed Neisseria meningitidis factor H-binding protein fHbp (rLP2086)
  著者:: Cendron, Laura, 等
  出版事項: (2011)
• Immunogenicity, Safety, and Tolerability of Bivalent rLP2086 Meningococcal Group B Vaccine Administered Concomitantly With Diphtheria, Tetanus, and Acellular Pertussis and Inactivated Poliomyelitis Vaccines to Healthy Adolescents
  著者:: Vesikari, Timo, 等
  出版事項: (2016)